Suchergebnisse - Vittorio Bertelè

  • Treffer 1 - 11 von 11
Treffer weiter einschränken
  1. 1
    Orphan drug development is not taking off

    Orphan drug development is not taking off von Roberta Joppi, Vittorio Bertelè, Silvio Garattini

    Veröffentlicht 2009
    Volltext Volltext
    Editorial
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Orphan drug development is progressing too slowly

    Orphan drug development is progressing too slowly von Roberta Joppi, Vittorio Bertelè, Silvio Garattini

    Veröffentlicht 2006
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures

    Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures von Giovanni Apolone, Roberta Joppi, Vittorio Bertelè, Silvio Garattini

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Older patients are still under-represented in clinical trials of Alzheimer’s disease

    Older patients are still under-represented in clinical trials of Alzheimer’s disease von Rita Banzi, Paolo Camaioni, Mauro Tettamanti, Vittorio Bertelè, Ugo Lucca

    Veröffentlicht 2016
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Clinical Outcome and its Predictors in 1560 Patients with Critical Leg Ischaemia

    Clinical Outcome and its Predictors in 1560 Patients with Critical Leg Ischaemia von Vittorio Bertelè, Maria Carla Roncaglioni, J Pangrazzi, Emanuela Terzian, Gianni Tognoni

    Veröffentlicht 1999
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials

    New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials von V.L. Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D’Amico, Vittorio Bertelè, Tommaso Trenti

    Veröffentlicht 2018
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Barriers to the conduct of randomised clinical trials within all disease areas

    Barriers to the conduct of randomised clinical trials within all disease areas von Snezana Djurisic, Ana Rath, Sabrina Gaber, Silvio Garattini, Vittorio Bertelè, Sandra-Nadia Ngwabyt, Virginie Hivert, Edmund Neugebauer, Martine Laville, M. Hiesmayr, Jacques Demotes‐Mainard, Christine Kubiak, Janus Christian Jakobsen, Christian Gluud

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them

    Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them von Silvio Garattini, Janus Christian Jakobsen, Jørn Wetterslev, Vittorio Bertelè, Rita Banzi, Ana Rath, Edmund Neugebauer, Martine Laville, Yvonne Masson, Virginie Hivert, Michaela Eikermann, Burç Aydın, Sandra Ngwabyt, Cecília Martinho, Chiara Gerardi, Cezary Szmigielski, Jacques Demotes‐Mainard, Christian Gluud

    Veröffentlicht 2016
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Specific barriers to the conduct of randomised clinical trials on medical devices

    Specific barriers to the conduct of randomised clinical trials on medical devices von Edmund Neugebauer, Ana Rath, Sunya-Lee Antoine, Michaela Eikermann, Doerthe Seidel, Carsten Koenen, Esther Jacobs, Dawid Pieper, Martine Laville, Séverine Pitel, Cecília Martinho, Snezana Djurisic, Jacques Demotes‐Mainard, Christine Kubiak, Vittorio Bertelè, Janus Christian Jakobsen, Silvio Garattini, Christian Gluud

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration von Lorenzo Moja, Ersilia Lucenteforte, Koren Hyogene Kwag, Vittorio Bertelè, Annalisa Campomori, Usha Chakravarthy, Roberto D’Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon K. Loke, Maureen G. Maguire, Daniel Martín, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby C Reeves, Chris Rogers, Christine Schmucker, Manju L. Subramanian, Gianni Virgili

    Veröffentlicht 2014
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration von Lorenzo Moja, Ersilia Lucenteforte, Koren Hyogene Kwag, Vittorio Bertelè, Annalisa Campomori, Usha Chakravarthy, Roberto D’Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon K. Loke, Maureen G. Maguire, Daniel Martín, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby C Reeves, Chris Rogers, Christine Schmucker, Manju L. Subramanian, Gianni Virgili

    Veröffentlicht 2014
    Volltext
    Referência Bibliográfica
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: